Virtual Program

Our 2-day virtual summit, to be held 20-21 September, features thought-provoking plenary sessions, topical presentations and discussions, educational symposia and speakers from a diverse array of backgrounds excited to share with you a wealth of ideas, experiences, and perspectives on the latest HEOR topics in Asia Pacific. 

Special Bonus: Registration includes extended access to all session playback recordings through 21 October 2022.

Note: Times shown within the program are in Korean Standard Time (KST). The Summit will be presented in English without translation.

Determining the Potential Payoff at City and District Levels From Up-Front Investments in New Technologies for Dengue Prevention in Two Endemic Countries (Thailand and Indonesia): Combining Surveillance, Screening and Interviewing

Speaker(s)

Discussion Leader: Donald Shepard, PhD, MPP, FASTMH, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA
Discussants: Sukhontha Kongsin, PhD, Faculty of Public Health, Mahidol University, Bangkok, Thailand; Nandyan Nurlaksana Wilastonegoro, MD, MScIH, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia

Presentation Documents

PURPOSE: Recent randomized trials of two new technologies (Wolbachia and Takeda's vaccine) established that each would cut dengue by ~75% without adverse effects. However, deployment would require substantial up-front investment, particularly at the city and district levels. Most existing studies overlook the many non-hospitalized cases, which impose substantial economic costs from healthcare utilization and lost productivity, thereby understating costs.

DESCRIPTION: Workshop attendees will obtain a working knowledge of approaches to provide needed data accurately, quickly, and efficiently. Prof. Shepard will lead the session and introduce the topic, describing the new technologies and limitations of existing studies. For example, dengue and other illnesses, including COVID-19, reduce presenteeism--patients' ability to maintain usual activities for income, household tasks, and schooling (10 min). Prof. Kongsin and colleagues piloted a study assessing presenteeism losses in Umphang District, Tak Province, Thailand. The pilot enrolled 22 laboratory-confirmed dengue patients, aged 7-78, from April-July, 2021 with interviews every 1-4 weeks for up to 6 months until symptoms ended. Enrollees reflected the diverse ages of dengue patients (14% under age 18, 72% aged 19-59, and 14% age 60+) and their distinct settings (27% inpatient and 73% outpatient). With participant incentives and well-trained staff, all enrollees completed every planned interview (15 min). Dr. Wilastonegoro will describe a five-step protocol for Semarang City, Indonesia (population 1.7 million): (1) Using data from the surveillance system to select a small but representative sample of public and private health centers and hospitals. (2) Promptly screening their clinically diagnosed patients for laboratory confirmation. (3) Inviting NS1-positive patients to enroll in an observational study. (4) Interviewing consenting patients every 1-4 weeks about health care utilization, absenteeism, and presenteeism. (5) Linking interviews with surveillance and screening data to weight to the city level (15 min). Audience participation in this interactive workshop will explore wider applicability and adaptation (20 min).

Code

W9